Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions

Human and Experimental Toxicology

Volumn 30, Issue 4, 2011, Pages 259-266

  Halpern, Pinchas ^a,e   Moskovich, Jenny ^b   Avrahami, Beni ^c   Bentur, Yedidia ^d   Soffer, Dror ^a   Peleg, Kobi ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c Addictions Authority Drugs Alcoholism Prisoners Rehabilitation Homeless   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

ecstasy; emergency admissions; Israel; morbidity; nationwide survey

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGITATION; ANXIETY; ARTICLE; ASSOCIATION; BLOOD CLOTTING DISORDER; BLURRED VISION; BRAIN EDEMA; COGNITIVE DEFECT; COMA; CYANOSIS; DEHYDRATION; DEPRESSION; DISORIENTATION; DISTRESS SYNDROME; DIZZINESS; DRUG ABUSE; DRUG USE; EMERGENCY WARD; EMPATHY; FACIAL EXPRESSION; FAINTNESS; FEMALE; HEADACHE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPONATREMIA; ILLUSION; INTENSIVE CARE UNIT; LOGORRHEA; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MOOD CHANGE; MORBIDITY; MUSCLE CRAMP; MYDRIASIS; NAUSEA; PANIC; PARANOIA; PARESTHESIA; PNEUMONIA; POISON CENTER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY ARREST; RESTLESSNESS; RHABDOMYOLYSIS; SEIZURE; SPEECH DISORDER; STROKE; SUICIDAL IDEATION; SWEATING; TACHYCARDIA; UNCONSCIOUSNESS; VIOLENCE;

ADOLESCENT; ADULT; EMERGENCY SERVICE, HOSPITAL; FEMALE; HALLUCINOGENS; HUMANS; ISRAEL; MALE; MORBIDITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PROSPECTIVE STUDIES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 79953102009     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110370984     Document Type: Article

References (35)

1. Suarez RV, Riemersma R. "Ecstasy" and sudden cardiac death. Am J Forensic Med Pathol 1988 ; 9: 339-341.
2. Steele TD, NcCann UD, Ricaurte GA 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction 1994 ; 89: 539-551. (Pubitemid 24160082)
3. The Israel Ministry of Health (Hebrew). 'Drugs-Psychoactive Substances', http://www.health.gov.il/pages/default.asp?PageId=3859&parentId= 3648&catId-660&maincat=35 (accessed 17 June 2007 ).
4. Curran HV, Travill RA Mood and cognitive effects of +/-3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction 1997 ; 92: 821-831. (Pubitemid 27326235)
5. Parrott AC, Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 1998 ; 139: 261-268. (Pubitemid 28439526)
6. Green AR, Cross AJ, Goodwin GM Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy'). Psychopharmacology 1995 ; 119: 247-260.
7. McGuire P., Fahy T. Chronic paranoid psychosis after misuse of MDMA ('ecstasy'). Br Med J 1991 ; 302: 697.
8. Benazzi F., Mazzoli M. Psychiatric illness associated with 'ecstasy. ' Lancet 1991 ; 338: 1520.
9. Baumann MH, Rothman RB 3,4-Methyleneioxy methamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 2007 ; 189: 407-424. (Pubitemid 44791212)
10. Barrett PJ, Taylor GT 'Ecstasy' ingestion: a case report of severe complications. J R Soc Med 1993 ; 86: 233-234. (Pubitemid 23103691)
11. Henry JA, Jeffereys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy'). Lancet 1992 ; 340: 384-387.
12. Brown C., Osterloh J. Multiple complications from recreational ingestion of MDMA ('ecstasy'). JAMA 1987 ; 258: 780-781. (Pubitemid 17135891)
13. Parr MJ, Low HM, Botterill P. Hyponatremia and death after 'ecstasy' injection. Med J Aust 1997 ; 166: 136-137.
14. Koesters SC, Rogers PD, Rajasingham CR MDMA ('ecstasy') and other 'club drugs': the new epidemic. Pediatr Clin North Am 2002 ; 49: 415-433. (Pubitemid 34441068)
15. Jager G., de Win MM, Vervaeke HK, Schilt T., Kahn RS, van den Brink W., et al. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology 2007 ; 193: 403-414. (Pubitemid 47063513)
16. Jager G., de Win MM, van der Tweel I., Schilt T., Kahn RS, van den Brink W., et al. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an fMRI study. Neuropsychopharmacology 2008 ; 33: 247-258. (Pubitemid 350243356)
17. Israel Police Reports, issue 181, http://www.police.gov.il/persumim/ kitvey-et/01-181/09-181.asp (accessed 28 October 2006 ).
18. Rahav G., Teichman M., Rosenbloom Y., Bar-Hamburger R. The authority on drug control. Use of psychotic materials by Israeli residents, 2001. Epidemiological Research 5 (Hebrew). Israel: National Institute for Anti-drugs, 2002.
19. ED Visits 2007. 'The Israel Ministry of Health' (Hebrew). http://www.health.gov.il/Download/pages/RD-avchanut07.pdf (accessed 3 March 2010 ).
20. Weir E. Raves: a review of the culture, the drugs and the prevention of harm. Can Med Assoc J 2000 ; 162: 1843-1848. (Pubitemid 30463158)
21. Lenton S., Boys A., Noreross K. Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia. Addiction 1997 ; 92: 1327-1337. (Pubitemid 27470122)
22. Schifano F., Corkery J., Naidoo V., Oyefeso A., Ghodse H. Overview of amphetamine-type stimulant mortality data- UK, 1997-2007. Neuropsychobiology 2010 ; 61: 122-130.
23. Degenhardt L., Roxburgh A., Dunn M., Campbell G., Bruno R., Kinner SA, et al. The epidemiology of ecstasy use and harms in Australia. Neuropsychobiology 2009 ; 60: 176-187.
24. Gross SR, Barrett SP, Shestowsky JS, Pihl RO Ecstasy and drug consumption patterns: a Canadian rave population study. Can J Psychiatry 2002 ; 47: 546-551.
25. Schifano F. Potential human neurotoxicity of MDMA ('ecstasy'): subjective self-reports, evidence from an Italian drug addiction center and clinical case studies. Neuropsychobiology 2000 ; 42: 25-33. (Pubitemid 30436313)
26. Drug Abuse Warning Network. 'The DAWN Report', http://www.oas.samhsa.gov (accessed 20 February 2007 ).
27. Topp L., Hando J., Dillon P., Roche A., Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 1999 ; 55: 105-115. (Pubitemid 29222009)
28. Williams H., Dratcu L., Taylor R., Roberts M., Oyefeso A. "Saturday night fever": ecstasy related problems in a London accident emergency department. J Accid Emerg Med 1998 ; 15: 322-326.
29. Richards R., Bretz SW, Johnson EB, Turnipseed SD, Brofeldt BT, Derlet RW Methamphetamine abuse and emergency department utilization. West J Med 1999 ; 170: 198-202.
30. Sanjurjo E., Nogue S., Miro O., Munne P. Analysis of patients attended in an emergency department due ecstasy consumption. Med Clin 2004 ; 123: 90-92. (Pubitemid 38931550)
31. Schifano F., Oyefeso A., Corkery J., Cobain K., Jambert-Gray R., Martinotti G., et al. Death rates from ecstasy (MDMA,MDA) and polydrug use in England and Wales, 1996-2002. Hum Psychopharmacol Clin Exp 2003 ; 18: 519-524. (Pubitemid 37279233)
32. Gill JR, Hayes JA, deSouza IS, Marker E., Stajic M. Ecstasy (MDMA) deaths in New York city: a case series and review of the literature. J Forensic Sci 2002 ; 47: 121-126. (Pubitemid 34084163)
33. Neumark YD, Yoffe-Sheinman H., Glasser J., Bar-Hamburger R., Tulchinsky T. Drug and alcohol-related emergency department visits. Isr J Psychiatry Relat Sci 2002 ; 39: 133-139.
34. Berkowitz M., Beer M., Reiss A. The authority on drug control. 'Clinical characteristics of children and teens treated at Assaf Harofe Hospital for use of drugs and alcohol' (Hebrew). http://www.antidrugs.org.il/template/default. asp?maincat=12&catId=41&pageId=551&parentId=224 ( 2004, accessed 2 February 2007 ).
35. Ben-Abraham R., Szold O., Rudick V., Weinbroum A. 'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting. Eur J Emerg Med 2003 ; 10: 309-313.